Sign up to save your podcasts
Or
Share Anthracycline Cardiotoxicity in Cancer Patients; Arrhythmias, Autonomic Dysfunction and COVID-19; Lowering Non–HDL Cholesterol After MI
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Anthracycline Cardiotoxicity in Cancer Patients; Arrhythmias, Autonomic Dysfunction and COVID-19; Lowering Non–HDL Cholesterol After MI
In this week’s View, Dr. Eagle looks at anthracycline cardiotoxicity in treatment of cancer patients. He then explores a scientific statement from the American Heart Association on cardiac arrhythmias and autonomic dysfunction associated with COVID-19. Finally, Dr. Eagle discusses the SWEDEHEART registry and intensive early and sustained lowering of non–HDL cholesterol after MI and prognosis.
Subscribe to Eagle’s Eye View
View all episodes
By American College of Cardiology
4.7
127127 ratings
In this week’s View, Dr. Eagle looks at anthracycline cardiotoxicity in treatment of cancer patients. He then explores a scientific statement from the American Heart Association on cardiac arrhythmias and autonomic dysfunction associated with COVID-19. Finally, Dr. Eagle discusses the SWEDEHEART registry and intensive early and sustained lowering of non–HDL cholesterol after MI and prognosis.
Subscribe to Eagle’s Eye View
More shows like Eagle's Eye View: Your Weekly CV Update From ACC.org
View all
JAMA Editors' Summary
130 Listeners
NEJM This Week
324 Listeners
JACC Podcast
159 Listeners
This Week in Cardiology
866 Listeners
JAMA Clinical Reviews
492 Listeners
Circulation on the Run
32 Listeners
Mayo Clinic Talks
277 Listeners
JAMA Medical News
87 Listeners
Core IM | Internal Medicine Podcast
1,087 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
60 Listeners
ACC CardiaCast
39 Listeners
Annals On Call Podcast
186 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Cardionerds: A Cardiology Podcast
424 Listeners
Mayo Clinic Cardiovascular CME
35 Listeners